ArticleScientific reports2018

Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models.

Mario Sechi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.